| Product Code: ETC6188955 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The Postoperative Pain management market in Australia is shaped by the growing number of surgical procedures and demand for effective pain relief options. Opioids, NSAIDs, and regional anesthesia techniques dominate treatment, but there is a notable shift toward multimodal pain management strategies to reduce opioid dependency and enhance recovery.
Australias postoperative pain market continues to grow, with a shift from opioid-based pain management to multimodal and regional anesthesia approaches. There is strong demand for non-opioid analgesics, long-acting local anesthetics, and patient-controlled analgesia systems. Regulatory pressure to curb opioid misuse is shaping pharmaceutical innovation.
The postoperative pain treatment market in Australia faces the dual challenge of addressing pain management effectively while curbing opioid dependency. Stricter prescribing regulations and the push for non-opioid alternatives necessitate innovation but raise costs and complexity for healthcare providers. Additionally, inconsistent post-surgical care protocols across hospitals hinder uniform market strategies.
Australia postoperative pain management market offers room for growth in the development of non-opioid analgesics, drug delivery systems, and digital pain monitoring tools. With regulatory pressures to reduce opioid dependency, companies focusing on innovative pain control mechanisms can attract strong investor interest and clinical partnerships.
The Australia government supports postoperative pain management through clinical guidelines, safe opioid prescribing initiatives, and PBS-subsidized analgesics. There are also regulatory controls enforced by the TGA around the use of opioid and non-opioid medications to balance effective pain relief with minimizing the risk of addiction.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Postoperative Pain Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Postoperative Pain Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Postoperative Pain Market - Industry Life Cycle |
3.4 Australia Postoperative Pain Market - Porter's Five Forces |
3.5 Australia Postoperative Pain Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Australia Postoperative Pain Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 Australia Postoperative Pain Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Australia Postoperative Pain Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing number of surgical procedures in Australia |
4.2.2 Growing awareness about the importance of effective postoperative pain management |
4.2.3 Rising prevalence of chronic diseases leading to higher postoperative pain cases |
4.3 Market Restraints |
4.3.1 Stringent regulations and guidelines related to opioid use for postoperative pain management |
4.3.2 Limited access to advanced pain management techniques in certain regions of Australia |
5 Australia Postoperative Pain Market Trends |
6 Australia Postoperative Pain Market, By Types |
6.1 Australia Postoperative Pain Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Australia Postoperative Pain Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 Australia Postoperative Pain Market Revenues & Volume, By Opioids, 2021- 2031F |
6.1.4 Australia Postoperative Pain Market Revenues & Volume, By NSAIDs, 2021- 2031F |
6.1.5 Australia Postoperative Pain Market Revenues & Volume, By Local Anesthetic, 2021- 2031F |
6.1.6 Australia Postoperative Pain Market Revenues & Volume, By Acetaminophen, 2021- 2031F |
6.2 Australia Postoperative Pain Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 Australia Postoperative Pain Market Revenues & Volume, By Injectable, 2021- 2031F |
6.2.3 Australia Postoperative Pain Market Revenues & Volume, By Oral, 2021- 2031F |
6.2.4 Australia Postoperative Pain Market Revenues & Volume, By Topical, 2021- 2031F |
6.2.5 Australia Postoperative Pain Market Revenues & Volume, By Transdermal, 2021- 2031F |
6.2.6 Australia Postoperative Pain Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Australia Postoperative Pain Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Australia Postoperative Pain Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.3.3 Australia Postoperative Pain Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.3.4 Australia Postoperative Pain Market Revenues & Volume, By Drug Stores, 2021- 2031F |
6.3.5 Australia Postoperative Pain Market Revenues & Volume, By Clinics, 2021- 2031F |
6.3.6 Australia Postoperative Pain Market Revenues & Volume, By Others, 2021- 2031F |
7 Australia Postoperative Pain Market Import-Export Trade Statistics |
7.1 Australia Postoperative Pain Market Export to Major Countries |
7.2 Australia Postoperative Pain Market Imports from Major Countries |
8 Australia Postoperative Pain Market Key Performance Indicators |
8.1 Average length of hospital stay post-surgery |
8.2 Utilization rate of non-opioid pain management methods |
8.3 Patient satisfaction with postoperative pain management services |
8.4 Rate of adoption of new pain management technologies |
8.5 Number of postoperative pain management clinics or centers opened across Australia |
9 Australia Postoperative Pain Market - Opportunity Assessment |
9.1 Australia Postoperative Pain Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Australia Postoperative Pain Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 Australia Postoperative Pain Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Australia Postoperative Pain Market - Competitive Landscape |
10.1 Australia Postoperative Pain Market Revenue Share, By Companies, 2024 |
10.2 Australia Postoperative Pain Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here